A new U.K. biotech has been set up by former researchers at GlaxoSmithKline PLC‘s discontinued neurosciences discovery unit and has just raised £11.5 million ($18.4 million) in a Series A financing led by Novo AS and Advent Venture Partners, and including GSK as an investor.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?